Clinical Trial Update: Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating efficacy, tolerability, and safety of Derinat for respiratory infections in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infections in Children

Drugs mentioned

• Derinat

Snippet

Sponsor: PharmPak, LLC | Conditions: Respiratory Infections in Children | Phase 3 | Status: UNKNOWN